CompletedNCT02157077
Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration
PHASE3 · 84 planned enrolment
- Countries listed
- 1
- Registry update
- October 5, 2026
Source-linked trial list
The registrations behind this number.
Verify the exact trial registrations behind a company, intervention, programme or topic count.
Exact trial list
3 matching trial registrations
- Intervention Aflibercept
Showing 1–3 of 3. Every record below meets all the filters shown above.
RecruitingNCT07440225
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
PHASE2 · PHASE3 · 960 planned enrolment
- Countries listed
- 12
- Registry update
- October 2, 2026
RecruitingNCT07482176
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
PHASE3 · 534 planned enrolment
- Countries listed
- 1
- Registry update
- September 24, 2026